Market Research Report
China Pharmaceuticals & Healthcare Q3 2019
|Published by||Fitch Solutions, Inc.||Product code||209173|
|Published||Content info||96 Pages
Delivery time: 1-2 business days
|China Pharmaceuticals & Healthcare Q3 2019|
|Published: May 14, 2019||Content info: 96 Pages||
China remains one of the most attractive APAC markets for innovative drugmakers. In the coming years, the Chinese pharmaceutical market will grow modestly with medicine sales driven an ageing population and high disease burden. New regulatory pathways and improvements to China's drug approval process will bolster long-term growth opportunities for drugmakers. Although this is favourable to innovative drugmakers, patented drug sales will be limited by the government's drug pricing and reimbursement policies as well as other cost-containment measures.